415
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Investigation of intermolecular interactions and stability of verubecestat in the active site of BACE1: Development of first model from QM/MM-based charge density and MD analysis

, , , &
Pages 2339-2354 | Received 14 Feb 2018, Accepted 11 May 2018, Published online: 19 Nov 2018

References

  • Ahmed, M., Yar, M., Nassour, A., Guillot, B., Lecomte, C., & Jelsch, C. (2013). Experimental and theoretical charge density analysis of a bromoethyl sulfonium salt. The Journal of Physical Chemistry A, 117, 14267–14275. doi:10.1021/jp410301d
  • Akhil, K., Sudeep, R., Shubhandra, T., & Ashok, S. (2016). Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. Journal of Biomolecular Structure and Dynamics, 24, 239–249. doi:10.1080/07391102.2015.1022603.
  • Akhil, K., Gaurava, S., Arvind, S. N., & Ashok, S. (2018). Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β. Journal of Biomolecular Structure and Dynamics, 36, 1–16. doi:10.1080/07391102.2018.1426043
  • Alison, R., & Nark, R. (1995). Molecular geometry. Jordan Hill, Oxford: Butterworth-Heinemann Ltd, Linacre House.
  • Alkorta, E. E., & Molins, J. E. E. (2002). From weak to strong interactions: A comprehensive analysis of the topological and energetic properties of the electron density distribution involving systems. The Journal of Chemical Physics, 117, 5529. doi:10.1063/1.1501133
  • Anantha Krishnan, D., Manish, K., Velmurugan, D., & Gunasekaran, K. (2017). Identification of new BACE1 inhibitors using pharmacophore and molecular dynamics approach. Journal of Molecular Graphics and Modelling, 76, 56–69. doi:10.1016/j.jmgm.2017.06.001
  • Andujar, A. S., Tosso, D. R., Suvire, D. F., Angelina, E., Peruchena, N., Cabedo, N., … Enriz, D. R. (2012). Searching the “biologically relevant” conformation of dopamine: A computational approach. Journal of Chemical Information and modeling, 52, 99–112. doi:10.1021/ci2004225
  • Andrew, J., & Ben, L. (2011). Adaptive stochastic methods for sampling driven molecular systems. The Journal of Chemical Physics, 135(084125), 11 pages. doi:10.1063/1.3626941
  • Anil, K., Arti, S., & Ekavali. (2015). A review on Alzheimer’s disease pathophysiology and its management: An update. Pharmacological Reports, 67, 195–203. doi:10.1016/j.pharep.2014.09.004
  • Aray, Y., Garcia, A. R., & Daniel, R. I. (2018). Exploring the nature of the H-bonds between the human class II MHC protein, HLA-DR1 (DRB*0101) and the influenza virus hemagglutinin peptide, HA306-318, using the quantum theory of atoms in molecules. Journal of Biomolecular Structure and Dynamics, 36, 1–17. doi:10.1080/07391102.2017.1418432.
  • Bader, R. F. W. (1994). Atoms in molecules: A quantum theory: International series of Monographs in chemistry (p. 24). Oxford, UK: Oxford University Press.
  • Bader, R. F. W., Tal, Y., Anderson, S. G., & Nguyen-Dang, T. T. (1980). Quantum topology: Theory of molecular structure and its change. Israel Journal of Chemistry, 19, 8–29. doi:10.1002/ijch.198000003
  • Barman, A., Schurer, S., & Prabhakar, R. (2011). Computational modeling of substrate specificity and catalysis of the β-secretase (BACE1) enzyme. Biochemistry, 50, 4337–4349. doi:10.1021/bi200081h
  • Barman, A., & Prabakar, R. (2013). Elucidating the catalytic mechanism of β-secretase (BACE1): A quantum mechanics/molecular mechanics (QM/MM) approach. Journal of Molecular Graphics and Modelling, 40, 1–9. doi:10.1016/j.jmgm.2012.12.010
  • Bastian, D., & Stefan, F. L. (2012). The membrane-bound aspartyl protease BACE1: Molecular and functional properties in Alzheimer’s disease and beyond. Frontiers in Physiology, 3(1), 16 pages. doi:10.3389/fphys.2012.00008
  • Bayer, T. A., & Wirths. O. (2010). Intracellular accumulation of amyloid-Beta - a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Frontiers in Aging Neuroscience, 2(8), 10 pages. doi:10.3389/fnagi.2010.00008
  • Benoit, G., Jelsch, C., Podjarny, A., & Lecomate, C. (2008). Charge-density analysis of a protein structure at subatomic resolution: The human aldose reductase case. Acta Crystallographica Section D, 64, 567–588. doi:10.1107/S0907444908006082
  • Berendsen, H. J. C., Postma, J. P. M., Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81, 3684–3690. doi:10.1063/1.448118
  • Case, D. A., Babin, V., Berryman, J. T., Betz, R. M., Cai, Q., Cerutti, D. S., … Kollman, P. A. (2014). AMBER 14, University of California, San Francisco.
  • Cavallo, G., Metrangolo, P., Milani, R., Pilati, T., Priimagi, A., Resnati, G., & Terraneo, G. (2016). The halogen bond. Chemical Reviews, 116, 2478–2601. doi:10.1021/acs.chemrev.5b00484
  • Cheeseman, J., Keith, T. A., & Bader, R. F. W. (1992). AIMPAC Program Package. Hamilton, ON: McMaster University.
  • Chopra, K., Misra, S., & Kuhad, A. (2011). Current perspectives on pharmacotherapy of Alzheimer’s disease. Expert Opinion on Pharmacotherapy, 12, 335–350. doi:10.1517/14656566.2011.520702
  • Chopra, D., Cameron, T. S., Ferrara, J. D., & Guru Row, T. N. (2006). Pointers toward the occurrence of C–F⋯F–C interaction charge density analysis of 1-(4-fluorophenyl)-6-methoxy-2-phenyl-1,2,3,4-tetrahydroisoquinoline. The Journal of Physical Chemistry A, 110, 10465–10477. doi:10.1021/jp0625309
  • Christian, H. (1998). Molecular biology of Alzheimer’s disease: Genes and mechanisms involved in amyloid generation. The Netherlands: Harwood Academic.
  • Ciordia, M., Benito, P, L., Delgado, F., Trabanco, A. A., & Tresadern, G. (2016). Application of free energy perturbation for the design of BACE1 inhibitors. Journal of Chemical information and modeling, 56, 1856–1871. doi:10.1021/acs.jcim.6b00220.
  • Colin, L. M., Randall, B., Kaj, B., Christopher, C. R., Reisa, A. S., & Jeffrey, L. C. (2015). Alzheimer’s disease. Nature Reviews Disease Primers, 1, 1–18. doi:10.1038/nrdp.2015.73
  • Daniel, R. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9, 3084–3095. doi:10.1021/ct400341p
  • Davidson, R. E., & Feller, D. (1988). Basis set selection for molecular calculations. Chemical Reviews, 86, 661–696. doi:10.1021/cr00074a002
  • David, E. H., Jacob, O., James, A. P., Mark, P. W., & Michael, B. H. (2004). Experimental and theoretical charge density studies of tetrafluorophthalonitrile and tetrafluoroisophthalonitrile. The Journal of Physical Chemistry B, 118, 3663–3672. doi:10.1021/jp037700l
  • David, S. A., Hathwar, V. R., Guru Row, T. N., & Kumaradhas, P. (2012). Topological electron density analysis and electrostatic properties of aspirin: An experimental and theoretical study. Crystal Growth & Design, 12, 4357–4366. doi:10.1021/cg300269n
  • Devipriya, B., & Kumaradhas, P. (2013). Molecular flexibility and the electrostatic moments of curcumin and its derivatives in the active site of p300: A theoretical charge density study. Chemico-Biological Interactions, 204, 153–165. doi:10.1016/j.cbi.2013.05.002
  • DeLano, W. L. (2002). PyMol molecular graphics system. San Carlos, CA: DeLano Scientific.
  • Domagala, S., Munshi, P., Ahmed, M., Guillot, B., & Jelsch, C. (2011). Structural analysis and multipoie modelling of quercetin monohydrate – a quantitative and comparative study. Acta Crystallographica Section B, 63, 1–16. doi:10.1107/S0108768110041996
  • Edwin, M. M., James, W. S., & Yamamoto, J. (1989). Novel approaches to the treatment of Alzheimer’s disease. New York, NY: Plenum Press.
  • Elias, K. M., Mary, L., Michaelis, S. J., Enna, L., & Count., L. (2012). Current state of Alzheimer’s disease research and therapeutics. Kidlington, Oxford: Elsevier.
  • Frank, M. L., Kim. N. G., & Salvatore. O. (2007). Intracellular amyloid-β in Alzheimer’s disease. Nature Reviews Neuroscience, 8, 499–509. doi:10.1038/nrn2168
  • Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., … Pople, J. A. (2005). Gaussian 03, Revision D.1, Wallingford, CT: Gaussian.
  • Fischer, F. C. (1987). General Hartree-Fock program. Computer Physics Communications, 43, 355–365. doi:10.1016/0010-4655(87)90053-1
  • Gatti, C., & Macchi, P. (2012). Modern charge density analysis. New York, NY: Springer.
  • Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10, 449–461. doi:10.1517/17460441.2015.1032936
  • Ghiso, J., & Frangione. B. (2002). Amyloidosis and Alzheimer disease. Advanced Drug Delivery Reviews, 54, 1539–1551. doi:10.1016/S0169-409X(02)00149-7
  • Gillespie, R. J., & Popelier, P. L. A. (2001). Chemical bonding and molecular geometry from Lewis to electron density. New York, NY: Oxford University press.
  • Glenn, J. M., Adam, H., & Tuckerman, M. E. (1999). Molecular dynamics algorithms for path integrals at constant pressure. The Journal of Chemical Physics, 110, 3275–3290. doi:10.1063/1.478193
  • Gutierrez, J. L., Parravicini, O., Sanchez, E., Rodriguez, R., Cobo, J., & Enriz, D. R. (2018). New substituted aminopyrimidine derivatives as BACE1 inhibitors: In silico design, synthesis and biological assays. Journal of Biomolecular structure and Dynamics, 36, 1–18. doi:10.1080/07391102.2018.1424036
  • Hansen, N. K., & Coppens, P. (1978). Testing aspherical atom refinements on small-molecule data sets. Acta Crystallographica Section A, 34, 909–921. doi:10.1107/S0567739478001886
  • Hardy, J., & Selkoe. D. J. (2002). The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science, 297, 353–356. doi:10.1126/science.1072994
  • Hibbs, D. E., Overgaard, J., & Piltz, R. O. (2003). X-N Charge density analysis of the hydrogen bonding motif in 1-(2-hydroxy-5nitropyeny) ethanone. Organic & Biomolecular Chemistry, 1, 1191–1198. doi:10.1039/B211683A
  • Hong, L., Turner, R. T., Koelsch, G., Shin, D., Ghosh, A. K., & Tang, J. (2002). Crystal structure of memapsin 2 (â-secretase) in complex with an inhibitor OM00-3. Biochemistry, 41, 10963–10967. doi:10.1021/bi026232n
  • Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD-visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38. doi:10.1016/0263-7855(96)00018-5
  • Induced Fit docking protocol. (2014). Small-molecular drug discovery suite 2014-2, version 6.3. New York, NY: Schrodinger.
  • James, J. P. S. (1989). Optimization of parameters for semi empirical methods I. Method. Journal of Computational Chemistry, 10, 209–220. doi:10.1002/jcc.540100208
  • James, A. M., Carmenza, M., Koushik, K., Lauren, W., Kevin, H., & Carlos, S. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11, 3696–3713. doi:10.1021/acs.jctc.5b00255
  • Jean, P. R., Giovanni, C., & Herman, J. C. B. (1977). Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. The Journal of Chemical Physics, 23, 327–341. doi:10.1016/0021-9991(77)90098-5
  • Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118, 11225–11236. doi:10.1021/ja9621760
  • Kalaiarasi, C., Pavan, M. S., & Kumaradhas, P. (2016). Topological characterization of electron density, electrostatic potential and intermolecular interactions of 2-nitroimidazole: An experimental and theoretical study. Acta Crystallographica Section B, 72, 775–786. doi:10.1107/S2052520616010581
  • Kennedy, M. E., Stamford, A. W., Chin, X., Cox, K., Cumming, J. N., Dockendorf, M. F., … Forman M. S. (2016). The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients. Science Translational Medicine, 8, 363ra150 (13 pages). doi:10.1126/scitranslmed.aad9704
  • Kerns, E. H., & Di, L. (2008). Drug-like properties: Concepts, structure design and methods: From ADME to toxicity optimization. Oxford, UK: Elsevier’s Science and Technology Rights Department.
  • Kim, M. O., Blachly, P. G., & McCammon, A. (2015). Conformational dynamics and binding free energies of inhibitors of BACE1: From the perspective of protonation Equilibria. PLoS: Computational Biology, 11, e1004341. doi:10.1371/journal.pcbi.1004341
  • Koritsanszky, T., Macchi, P., Gatti, C., Farrugia, L. J., Mallinson, P. R., Volkov, A., & Richter, T. (2007). XD-2006. A computer program package for multipole refinement and topological analysis of charge densities and evaluation of intermolecular energies from experimental or theoretical structure factors. Glasgow: University of Glasgow. 5, 33.
  • Kumar, A., Roy, S., Tripathi, S., & Sharma, A. (2015). Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis. Journal of Biomolecular Structure and Dynamics, 34, 239–249. doi:10.1080/07391102.2015.1022603
  • Labanowski, J. K., & Andzelm, J. W. (1991). Density functional methods in chemistry. New York, NY: Springer.
  • Lai, F., Du, J. J., Williams, P. A., Varadi, L., Baker, D., Groundwater, P. W., … Hibbs. D. E. (2016). A comparison of the experimental and theoretical charge density distributions in two polymorphic modifications of piroxicam. Physical Chemistry Chemical Physics, 18, 28802–28818. doi:10.1039/C6CP02690G
  • Leeson, P. (2012). Chemical beauty contest. Nature, 481, 455–456. doi:10.1038/481455a
  • Leusser, D., Henn, J., Kocher, N., Engels, B., & Stalke, D. (2004). An experimental and theoretical charge density study. Journal of the American Chemical Society, 126, 1781–1793. doi:10.1021/ja076152c
  • Lewars E. G. (2016). The concept of the potential energy surface. In: Computational chemistry. Cham: Springer. doi:10.1007/978-3-319-30916-3_2
  • Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1, 337–341. doi:10.1016/j.ddtec.2004.11.007
  • Loren, D. M. (2004). ChemDraw 8 Ultra, Windows and Macintosh versions. Journal of Chemical Information and Modeling, 24, 2225–2226. doi:10.1021/ci040123t
  • Matta, C. F., Boyd, R. J., & Becke, A. (2007). The quantum theory of atoms in molecules from solid state to DNA and drug design. Weinheim, Germany: Wiley-VCH Verlag GmbH.
  • Matthew, P. J., David, L. P., Chaya, S. R., Tyler, J. F. T., Barry, H., David, E. S., … Friesner, A. (2004). Hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55, 351–367. doi:10.1002/prot.10613
  • Meyer, E. A., Castellano, R. K., & Diederich, F. (2003). Interactions with aromatic rings in chemical and biological recognition. Angewandte Chemie International Edition, 42, 1210–1250. doi:10.1002/anie.200390319
  • Michael, F. H., & Barbara, D. (2014). Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. The Journal of Chemical Physics, 140(174501), 14 pages. doi:10.1063/1.4872239
  • Miller, B. R., Dwight, M. J., Swails, J. M., Nadine, H., Holger, G., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for End-state free energy calculations. Journal of Chemical Theory and Computation, 8, 3314–3321. doi:10.1021/ct300418h
  • Mirjana, B. C., Danijela, Z. K., Tamara, D. L., Aleksandra, M. B., & Vesna. M. V. (2013). Acetylcholinesterase inhibitors: Pharmacology and toxicology. Current Neuropharmacology, 11, 315–335. doi:10.2174/1570159X11311030006
  • Munshi, P., Jelsch, C., Hathwar, V. R., & Guru Row, T. N. (2010). Experimental and theoretical charge density analysis of polymorphic structures: The case of Coumarin 314 dye. Crystal Growth & Design, 10, 1516–1526. doi:10.1021/cg900649m
  • Naudts, J., & Van der Straeten, E. (2006). A generalized quantum microcanonical ensemble. Journal of Statistical Mechanics: Theory and Experiment, 2006, P06015. doi:10.1088/1742-5468/2006/06/P06015
  • Park, H., & Lee, S. (2003). Determination of the active site protonation state of β-secretase from molecular dynamics simulation and docking experiment: Implications for structure based inhibitor design. Journal of the American Chemical Society, 125, 16416–16422. doi:10.1021/ja0304493
  • Parihar, M. S., & Hemnani, T. (2004). Alzheimer’s disease pathogenesis and therapeutic interventions. Journal of Clinical Neuroscience, 11, 456–467. doi:10.1016/j.jocn.2003.12.007
  • Parveen, M., & Kumar. S. (2005). Recent trends in the acetylcholinesterase system (Biomedical and Health Research). Amsterdam, The Netherlands: IOS press.
  • Parr, R. G., & Yang, W. (1989). Density functional theory of atoms and molecules. New York, NY: Oxford University Press.
  • Popelier, P. L. A. (2000). On the full topology of the Laplacian of the electron density. Coordination Chemistry Reviews, 197, 169–189. doi:10.1016/S0010-8545(99)00189-7
  • Popelier, P. L. A., Devereux, M., & Rafat, M. (2004). The quantum topological electrostatic potential as a probe for functional group transferability. Acta Crystallographica Section A, 60, 427–433. doi:10.1107/S0108767304016228
  • Politzer, P., Murray, J. S., & Peralta-inga, Z. (2011). Molecular surface electrostatic potentials in relation to noncovalent interactions in biological systems. International Journal of Quantum Chemistry, 81, 676–684. doi:10.1002/qua.1706
  • Prabu, M., Kiranmai, C., & Nanda, G. (2015). Target specific proteochemometric model development for BACE1 – protein flexibility and structural water are critical in virtual screening. Molecular BioSystems, 11, 1955–1972. doi:10.1039/c5mb00088b
  • Prabu, M., Kiranmai, C., & Nanda, G. (2018). Computational analysis of BACE1-ligand complex crystal structures and linear discriminant analysis for identification of BACE1 inhibitors with anti P-glycoprotein binding property. Journal of Biomolecular Structure and Dynamics, 36, 262–276. doi:10.1080/07391102.2016.1276477
  • Prabu, M., & Nanda, G. (2017). Fragment-based virtual screening approach and molecular dynamics simulation studies for identification of BACE1 inhibitor leads. Journal of Biomolecular Structure and Dynamics, 35, 1–15. doi:10.1080/07391102.2017.1337590
  • Prabu, M., Vijayan, R. S. K., & Nanda, G. (2010). Rationalizing fragment based drug discovery for BACE1: Insights from FB-QSAR, FB-QSSR, multi objective (MO-QSPR) and MIF studies. Journal of Computer Aided Molecular Design, 24, 843–864. doi:10.1007/s10822-010-9378-9
  • Rahman, A., & Choudhary, M. I. (2014). Drug design and discovery in Alzheimer’s disease. Kidlington, Oxford: Elsevier.
  • Rajalakshmi, G., Hathwar, V. R., & Kumaradhas, P. (2014). Topological analysis of electron density and the electrostatic properties of isoniazid: an experimental and theoretical study. Acta Crystallographica Section B, 70, 331–341. doi:10.1107/S2052520613033209
  • Rajalakshmi, G., Pavan, M. S., & Kumaradhas, P. (2014). Charge density distribution and electrostatic interactions of ethionamide: An inhibitor of the enoyl acyl carrier priteinreductase (inhA) enzyme of Mycobacterium tuberculosis. RSC Advances, 4, 57823–57833. doi:10.1039/C4RA07953A
  • Renuga Parameswari, A., Rajalakshmi, G., & Kumaradhas, P. (2015). A combined molecular docking and charge density analysis is a new approach for medicinal research to understand drug–receptor interaction: Curcumin–AChE model. Chemico-Biological Interactions, 225, 21–31. doi:10.1016/j.cbi.2014.09.011
  • Ribas, J., Cubero, E., Luque, F. J., & Orozco, M. (2002). Theoretical study of Alkyl-π and Aryl-π interactions. Reconciling theory and experiment. The Journal of Organic Chemistry, 67, 7057–7065. doi:10.1021/jo0201225
  • Saravanan, K., Kalaiarasi, C., & Kumaradhas, P. (2017). Understanding the conformation flexibility and electrostatic properties of curcumin in the active site of rhAChE via molecular docking, molecular dynamics, and charge density analysis. Journal of Biomolecular Structure and Dynamics, 35, 3627–3647. doi:10.1080/07391102.2016.1264891
  • Scott, J. D., Li, S. W., Brunskill, A. P. J., Chen, X., Cox, K., Cumming, J. N., … Stamford, A. W. (2016). Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)—A b-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease. Journal of Medicinal Chemistry, 59, 10435–10450. doi:10.1021/acs.jmedchem.6b00307
  • Selkoe, D. J., & Hardy, J. (2016). The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine, 8, 595–608. doi:10.15252/emmm.201606210
  • Sinnokrot, O. M., & David Sherrill, C. (2004). Substituent effects in π-π interactions: Sandwich and T-shaped configurations. Journal of the American Chemical Society, 126, 7690–7697. doi:10.1021/ja049434a
  • Sivanandam, M., Saravanan, K., & Kumaradhas, P. (2017). Insights into intermolecular interactions, electrostatic properties and the stability of C646 in the binding pocket of p300 histone acetyltransferase enzyme: A combined molecular dynamics and charge density study. Journal of Biomolecular Structure and Dynamics, 35, 1–19. doi:10.1080/07391102.2017.1384761
  • Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE – AnteChamber Python Parserinterface. BMC Research Notes, 5(367), 1–8. doi:10.1186/1756-0500-5-367
  • Stash, A. J., & Tsirelson, V. G. (2014). Developing WinXPRO: A software for determination of the multipole-model-based properties of crystals. Journal of Applied Crystallography, 47, 2086–2089. doi:10.1107/S1600576714021566
  • Steinmetz, K. L., & Spack, E. G. (2009). The basics of preclinical drug development for neurodegenerative disease indications. BMC Neurology, 9, 1–13. doi:10.1186/1471-2377-9-S1-S2
  • Tasi, G., Palinko, I., Nyerges, L., Fejes, P., & Forster, H. (1993). Calculation of electrostatic potential maps and atomic charges for large molecules. Journal of Chemical Information and Modeling, 33, 296–299. doi:10.1021/ci00013a003
  • Tettay, G. C., Zuchniarz, J., Fortich-Seca, Y., Gueto-Tettay, L. R., & Drosos-Ramirez, C. J. (2016). A molecular dynamics study of the BACE1 conformational change from Apo to closed form induced by Hydroxyethylamine derived compounds. Journal of Molecular Graphics and Modelling, 70, 181–195. doi:10.1016/j.jmgm.2016.10.006
  • Thaisrivongs, D. A., Miller, S. P., Molinaro, C., Chen, Q., Song, Z. J., Tan, L., … Xu, Y. (2016). Synthesis of Verubecestat, a BACE1 inhibitor for the treatment of Alzheimer’s Disease. Organic Letters, 18, 5780–5783. doi:10.1021/acs.orglett.6b01793
  • Turner, P. J. (2005). XMGRACE, Version 5.1.19. Beaverton, OR: Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology.
  • Venugopal, C., Demos, C. M., Jagannatha Rao, K. S., Pappolla, M. A., & Sambamurti, K. (2008). Beta secretase: Structure, function and evolution. CNS & Neurological Disorders - Drug Targets, 7, 278–294. doi:10.2174/187152708784936626
  • Vijayan, R. S. K., Prabu, M., Mascarenhas, N. M., & Nanda, G. (2009). Hybrid structure-based virtual screening protocol for the identification of novel BACE1 inhibitors. Journal Chemical Infirmation and Modeling, 49, 647–657. doi:10.1021/ci800386v
  • Xu, Y., Li, M. J., Greenblatt, H., Chen, W., Paz, A., Dym, O., … Sussman, J. L. (2012). Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations. Acta Crystallographica Section D, 68, 13–25. doi:10.1107/S0907444911047251
  • Yu, H., Kazuki, T., & Kunio, M. (2016). Charge density analysis of an iron-sulfur protein at an ultra-high resolution of 0.48 Å. Nature, 534, 281–284. doi:10.1038/nature18001
  • Yan, R. (2016). Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs. Translational Neurodegeneration, 5, 1–13. doi:10.1186/s40035-016-0061-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.